Dr Lisa McIntyre is an experienced company director with a broad portfolio spanning the healthcare, insurance, technology and e-learning sectors. She is currently a non-executive director of Insurance and Care NSW (a government public financial corporation), HCF Group (a private health insurance company in Australia), The University of Sydney, Studiosity and Nanosonics, and chair of LEK Consulting's ANZ Advisory Board. Prior to her director roles, Dr McIntyre spent 20 years as a senior strategy partner with LEK Consulting, where she helped develop the company's US biotechnology advisory practice from three clients in the emerging sector to become the largest biotechnology practice in the US, providing strategic, commercial and operational advice to local and multinational companies in North America, Asia and Australia. She has extensive knowledge in health and technology with experience in strategy, finance, technology transformation and data analytics, and a deep understanding of international markets.
PhD Physical Chemistry, Bachelor of Science – Biochemistry and Pure Maths
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.